In this episode, Dr. Andree Bates speaks with Dr. Jordan Lane, Chief Scientific Officer of Ignota Labs, about how explainable AI is transforming the pharmaceutical industry. They explore how Ignota Labs leverages AI to rescue drug projects that previously failed due to safety concerns.
Dr. Lane highlights the groundbreaking technology behind the Safe Path platform, which integrates chem-informatics and bioinformatics to address drug safety issues, potentially bringing valuable but shelved drugs back to market.
The conversation also touches on the challenges of using AI in drug discovery, particularly overcoming biases and ensuring transparency in the AI models. Dr. Lane shares real-world examples of how Igniter Labs has successfully applied its AI tools to save pharmaceutical assets. They also discuss the growing role of AI in the industry and the influence of regulatory bodies like the FDA and EMA on the adoption of AI-driven solutions in drug development.
Listen to the episode in full:
‘Rescuing failed drug projects: How Ignota’s explainable AI is transforming pharmaceuticals.’
Hosted by: Dr Andree Bates
Released: 23 October 2024 by AI for Pharma Growth
